Article info

Download PDFPDF
Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy

Authors

  • Jay Ramchand Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia PubMed articlesGoogle scholar articles
  • Thalys Sampaio Rodrigues Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia PubMed articlesGoogle scholar articles
  • Matias B Yudi Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia PubMed articlesGoogle scholar articles
  • Louise M Burrell Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jay Ramchand, Department of Medicine, Department of Cardiology, University of Melbourne, Parkville VIC 3010, Australia; jay.ramchand{at}unimelb.edu.au
View Full Text

Citation

Ramchand J, Sampaio Rodrigues T, Yudi MB, et al
Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy

Publication history

  • First published November 14, 2018.
Online issue publication 
November 14, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.